var data={"title":"Thrombin, topical (human and bovine): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Thrombin, topical (human and bovine): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/7047?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=thrombin-topical-human-and-bovine-drug-information\" class=\"drug drug_general\">see &quot;Thrombin, topical (human and bovine): Drug information&quot;</a> and <a href=\"topic.htm?path=thrombin-topical-human-and-bovine-patient-drug-information\" class=\"drug drug_patient\">see &quot;Thrombin, topical (human and bovine): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5708964\" class=\"block black-box-warn drugH1Div\"><span class=\"drugH1\">ALERT: US Boxed Warning</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Severe bleeding and thrombosis complications: Thrombin topical (bovine) only: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Thrombin topical (bovine) can cause fatal severe bleeding or thrombosis.  Thrombosis may result from the development of antibodies against bovine thrombin. Bleeding may result from the development of antibodies against factor V.  These may cross-react with human factor V and lead to its deficiency.  Do not re-expose patients to thrombin topical (bovine) if there are known or suspected antibodies to bovine thrombin and/or factor V.  Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227307\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Evithrom;</li>\n      <li>Recothrom;</li>\n      <li>Recothrom Spray Kit;</li>\n      <li>Thrombi-Gel;</li>\n      <li>Thrombi-Pad;</li>\n      <li>Thrombin-JMI;</li>\n      <li>Thrombin-JMI Epistaxis Kit;</li>\n      <li>Thrombin-JMI Pump Spray Kit;</li>\n      <li>Thrombin-JMI Syringe Spray Kit</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F44477156\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Recothrom</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062588\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Hemostatic Agent</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062584\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=thrombin-topical-human-and-bovine-drug-information\" class=\"drug drug_general\">see &quot;Thrombin, topical (human and bovine): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hemostasis:</b> Topical: <b>Note:</b> For topical use only; do not administer intravenously or intra-arterially:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Evithrom: Infants, Children, and Adolescents: Dose depends on area to be treated; may apply directly or in conjunction with an absorbable gelatin sponge; up to 10 mL was used with absorbable gelatin sponge in clinical studies</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Recothrom: Infants &ge;1 month, Children, and Adolescents: Dose depends on area to be treated including size of and number of bleeding sites; may apply directly or in conjunction with an absorbable gelatin sponge</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hemostasis:</b> Topical: <b>Note:</b> For topical use only; do not administer intravenously or intra-arterially:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Evithrom: Dose depends on area to be treated; up to 10 mL was used with absorbable gelatin sponge in clinical studies</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Recothrom: Dose depends on area to be treated</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Thrombi-Gel 10, 40, 100: Wet product with up to 3 mL, 10 mL, or 20 mL, respectively, NS or SWFI; apply directly over source of the bleeding with manual pressure</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Thrombi-Pad: Apply pad directly over source of bleeding; may apply dry or wetted with up to 10 mL of NS. If desired, product may be left in place for up to 24 hours; do not leave in the body. </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Thrombin-JMI:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Solution: Use 1,000 to 2,000 units/mL of solution where bleeding is profuse; use 100 units/mL for bleeding from skin or mucosal surfaces</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Powder: May apply powder directly to the site of bleeding or on oozing surfaces </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227299\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pad, topical [preservative free; bovine derived]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Thrombi-Pad 3x3: &ge;200 units (10s)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Powder for reconstitution, topical [bovine derived]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombin-JMI: 5000 units, 20,000 units [supplied with diluent] </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombin-JMI Epistaxis kit: 5000 units [supplied with diluent]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombin-JMI Pump Spray Kit: 20,000 units [supplied with diluents]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombin-JMI Syringe Spray Kit: 5000 units; 20,000 units [supplied with diluent]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder for reconstitution, topical [preservative free; recombinant]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Recothrom: 5000 units; 20,000 units [production involves products derived from hamster and snake sources; supplied with diluent]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Recothrom Spray Kit: 20,000 units [production involves products derived from hamster and snake sources; supplied with diluent] </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, topical [human derived]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Evithrom: 800-1200 units/mL (2 mL, 5 mL, 20 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Sponge, topical [preservative free; bovine derived]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombi-Gel 10: &ge;1000 units (10s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombi-Gel 40: &ge;1000 units (5s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Thrombi-Gel 100: &ge;2000 units (5s)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227286\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062591\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: For topical use only; do not administer intravenously or intra-arterially.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Evithrom: Must be thawed prior to use. May apply thawed solution directly or in combination with absorbable gelatin sponge; when using with absorbable gelatin sponge, knead thoroughly to saturate the pad and remove trapped air bubbles.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Recothrom: May apply reconstituted solution directly or in combination with absorbable gelatin sponge.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombi-Gel: May cut or roll to desired shape prior to wetting; once wetted and prior to applying, knead thoroughly to saturate the pad and remove trapped air bubbles.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombi-Pad: May apply dry or wet.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombin-JMI: May be applied directly as a powder or as reconstituted solution; sponge surface free of blood prior to application, if possible.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227306\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">All products: Store at 2&deg;C to 25&deg;C (36&deg;F to 77&deg;F) prior to reconstitution or wetting.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Evithrom: Protect from light.  Following reconstitution, may store at 2&deg;C to 25&deg;C (36&deg;F to 77&deg;F) for up to 8 hours. Do not freeze or refrigerate reconstituted solution.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Recothrom: Do not freeze. Following reconstitution, may store at 2&deg;C to 25&deg;C (36&deg;F to 77&deg;F) for up to 24 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombi-Gel: After wetting, use within 3 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombin-JMI: Solutions may be stored at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F) for up to 24 hours or at room temperature for up to 8 hours after reconstitution.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombi-Pad: If pad is wetted, use within 1 hour.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062590\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Hemostasis aid whenever minor bleeding from capillaries and small venules is accessible and control by standard surgical techniques is ineffective or impractical (Evithrom: FDA approved in pediatric patients [age not specified] and adults; Recothrom: FDA approved in ages &ge; 1 month and adults; Thrombin-JMI: FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Trauma dressing for temporary control of moderate-to-severe bleeding wounds; control of surface bleeding from vascular access sites and percutaneous catheter/ tubes (Thrombi-Gel; Thrombi-Pad: FDA approved in adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5663226\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Administration issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">For topical use only. Do not administer intravenously or intra-arterially.</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">To reduce the risk of intravascular administration, the Institute for Safe Medication Practices (ISMP) has the following recommendations:</p>\n        <p style=\"text-indent:-2em;margin-left:6em;\">- Prepare, label, and dispense topical thrombin from the pharmacy department (including doses used in the operating room).</p>\n        <p style=\"text-indent:-2em;margin-left:6em;\">- Do not leave vial or syringe at bedside.</p>\n        <p style=\"text-indent:-2em;margin-left:6em;\">- Add auxiliary label to all labels and syringes stating &ldquo;For topical use only - do not inject&rdquo;.</p>\n        <p style=\"text-indent:-2em;margin-left:6em;\">- When appropriate, use solutions which can be applied with an absorbable gelatin sponge or use a dry form on oozing surfaces.</p>\n        <p style=\"text-indent:-2em;margin-left:6em;\">- When appropriate, use spray kits to help differentiate between parenteral products.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227316\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cardiovascular: Thromboembolism</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dermatologic: Pruritus</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gastrointestinal: Nausea, vomiting</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Hematologic and oncologic: Increased INR, increased neutrophils, lymphocytopenia, prolonged partial thromboplastin time, prolonged prothrombin time</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Hypersensitivity: Hypersensitivity reaction</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Immunologic: Antibody development</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Local: Postoperative wound complication</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227303\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Known hypersensitivity to any component of the formulation.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Evithrom: Additional contraindications: Known anaphylactic or severe systemic reactions to blood products; treatment of severe or brisk arterial bleeding</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Recothrom: Additional contraindications: Known hypersensitivity to hamster proteins; injection directly into the circulatory system; treatment of massive or brisk arterial bleeding.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombi-Gel: Additional contraindications: Use in the closure of skin incisions.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombin-JMI: Additional contraindications: Known sensitivity to material of bovine origin; injection directly into the circulatory system; re-exposure if there are known or suspected antibodies to bovine thrombin and/or factor V; treatment of severe or brisk arterial bleeding.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thrombi-Pad: Additional contraindications: Known sensitivity to bovine-derived materials.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227290\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypersensitivity: Hypersensitivity reactions, including anaphylaxis, may occur. Institute supportive measure and treat individual symptoms immediately.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Human plasma product: Evithrom is a product of human plasma; may potentially contain infectious agents that could transmit infectious agents, such as viruses and, theoretically the Creutzfeldt-Jacob disease agent, or unknown infectious agents. Screening of donors, as well as testing and/or inactivation or removal of certain viruses, reduces the risk. Infections thought to be transmitted by this product should be reported to the manufacturer. </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Infection risk: Thrombi-Gel and Thrombi-Pad: Do not use in the presence of infection; use caution in areas of contamination.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Nonabsorbable product: Thrombi-Pad: Do not use as a replacement for absorbable hemostats. Product is nonabsorbable; do not leave in the body.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Proteins (snake and hamster origin): Recothrom: Use caution in patients with known hypersensitivity to snake or hamster proteins (manufacturing process uses a genetically modified hamster cell line and snake proteins); the potential for allergic reaction theoretically exists.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Severe bleeding and thrombosis complications: Thrombin-JMI, Thrombi-Gel, and Thrombi-Pad only. <b>[US Boxed Warning]: Thrombin topical (bovine) can cause fatal severe bleeding or thrombosis.  Thrombosis may result from the development of antibodies against bovine thrombin. Bleeding may result from the development of antibodies against factor V.  These may cross-react with human factor V and lead to its deficiency.  Re-exposure of patients with known or suspected antibodies to bovine thrombin and/or factor V should be avoided. Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Administration: For topical use only. Do not inject intravenously or intra-arterially. Intravascular clotting, possibly leading to death, may occur following injection. Powder and solution formulations may be used in combination with absorbable gelatin sponges.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300134\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227294\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12840&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227296\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5663227\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Reproduction studies conducted with the solvent/detergent used in processing the human-derived product (Evithrom) showed adverse events in animals. Only residual levels of the solvent/detergent would be expected to remain in the finished product. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F227289\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Activates platelets and catalyzes the conversion of fibrinogen to fibrin to promote hemostasis.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062594\" class=\"block adi drugH1Div\"><span class=\"drugH1\">Additional Information</span>\n    <p style=\"text-indent:0em;display:inline\">One unit is amount required to clot 1 mL of standardized fibrinogen solution in 15 seconds</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323961\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Thrombin-JMI Epistaxis External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5000 unit (1): $92.24</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Thrombin-JMI External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5000 unit (1): $87.85</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20000 unit (1): $356.64</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Thrombogen External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10000 unit (1): $34.39</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Pads</b> (Thrombi-Pad External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3&quot;X3&quot; (10): $680.65</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Evithrom External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">800-1200 units/mL (5 mL): $115.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (Recothrom External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5000 unit (1): $103.20</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20000 unit (1): $412.80</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (Recothrom Spray Kit External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20000 unit (1): $418.80</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (Thrombin-JMI External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5000 unit (1): $86.12</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20000 unit (1): $339.65</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (Thrombogen External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1000 unit (1): $3.60</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10000 unit (1): $18.02</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6038843\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Floseal (HK);</li>\n      <li>Thrombostat (NZ);</li>\n      <li>Trombine (NL)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Evithrom (thrombin, topical) [prescribing information]. Somerville, NJ: J&amp;J Wound Management; January 2009.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Recothrom (thrombin, topical) [prescribing information]. Seattle, WA: ZymoGenetics, Inc.; March 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Thrombi-Gel (thrombin) [prescribing information]. Bristol, TN: King Pharmaceuticals; June 2007.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Thrombi-Pad (thrombin) [prescribing information]. Bristol, TN: King Pharmaceuticals; April 2008.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Thrombin-JMI [prescribing information]. Middleton, WI: GenTrac, Incorporated; November 2007.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12840 Version 54.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"ALERT: US Boxed Warning\" href=\"#F5708964\" class=\"outlineLink\">ALERT: US Boxed Warning</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F227307\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F44477156\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1062588\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1062584\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F227299\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F227286\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1062591\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F227306\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1062590\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F5663226\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F227316\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F227303\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F227290\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300134\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F227294\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F227296\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F5663227\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F227289\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Additional Information\" href=\"#F1062594\" class=\"outlineLink\">Additional Information</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323961\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F6038843\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12840|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=thrombin-topical-human-and-bovine-drug-information\" class=\"drug drug_general\">Thrombin, topical (human and bovine): Drug information</a></li><li><a href=\"topic.htm?path=thrombin-topical-human-and-bovine-patient-drug-information\" class=\"drug drug_patient\">Thrombin, topical (human and bovine): Patient drug information</a></li></ul></div></div>","javascript":null}